SinoGenoMax Co. Ltd. of Beijing announced that it will partner with Cogenics, a division of Clinical Data, Inc.  to provide Cogenics’ clinical genotyping services in China. According to Cogenics, the top 20 pharmaceutical companies in the US and Europe are clients. Cogenics’ services include pharmacogenomics discovery and validation as well as biomarker research and development. More details...

Stock Symbol: (NSDQ: CLDA)